Remepy: Funding, Investors & Team (Sep 2026)
Remepy is biotechnology research pioneering hybrid drugs.
Remepy has raised $36.0M across 1 funding round on record, the most recent a Series A of $36.0M announced in Aug 2026.
That round is above the $14M median round size for Israel companies tracked on FundedIQ over the last two years.
Remepy Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Remepy Funding Rounds
Remepy Investors
18 investors are recorded in total; the 5 named above are those the record identifies.
Remepy Founders and Leadership Team
Contact details for the Remepy team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Remepy Funding in Context
Remepy's latest round of $36.0M is above the median round in Israel. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Remepy in Biotechnology and Ramat Gan
Companies Similar to Remepy
Guardio is a cyber security company. Guardio is a lightweight extension designed that helps to browse quickly…
Platform enabling enterprises to create, test, and deploy AI agents for voice, chat, and email.
Aitan is an advanced edge-AI robotic weapon systems developer for defense.
Huskeys is a cybersecurity company that develops an edge security management (ESM) platform designed to…
Lasso Security is a pioneering comprehensive LLM cybersecurity startup that is committed to addressing the…
Hibob was founded in 2015 to modernize HR tech. Hibob's intuitive and data-driven platform, bob, was built…
DataAgent is a transforming application performance monitoring (APM) by shifting the industry from reactive,…
AIR Security provides an AI security platform that secures AI agents and their add-ons, including skills,…
Swish Basket is an AI-powered basketball training and gaming platform that provides personalized coaching…
Corma develops foundation models and artificial intelligence systems for defensive cybersecurity.
Faye provides whole-trip travel coverage and care that brings out the best in each journey with…
By utilising runtime application context and leveraging the most exact open source security solution…
Remepy Funding FAQs
What does Remepy do?
Remepy is biotechnology research pioneering hybrid drugs.
How much funding has Remepy raised?
Remepy has raised $36.0M across 1 round on record. The most recent is a Series A of $36.0M announced in Aug 2026.
When did Remepy last raise funding?
Remepy's most recent funding round on record is a Series A of $36.0M, announced in Aug 2026.
Who has invested in Remepy?
Investors on record for Remepy include Tadmor Group, Qumra Capital, O.G. Venture Partners, Samsung NEXT, 97212 Ventures. FundedIQ records 18 investors in total.
Who founded Remepy?
FundedIQ lists Michal Tsur (Co-Founder & Co-CEO), Or Shoval (Co-Founder & Co-CEO) at Remepy.
Where is Remepy headquartered?
Remepy is based in Ramat Gan, Israel.
How many employees does Remepy have?
Remepy is in the 11-50 employee band.
When was Remepy founded?
Remepy was founded in 2022.
About FundedIQ's Remepy Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Remepy is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.